Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
AMGEN INC (AMGN)
Sector: Healthcare; Industry: Drug Manufacturers—General

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2019-07-03 SUGAR RONALD D Director Sell 2,000 $187.58 $375,160 Yes
2019-06-05 SUGAR RONALD D Director Sell 2,000 $175.68 $351,360 Yes
2019-05-01 SUGAR RONALD D Director Sell 2,000 $175.73 $351,460 Yes
2019-04-03 SUGAR RONALD D Director Sell 2,000 $193.18 $386,360 Yes
2019-03-06 SUGAR RONALD D Director Sell 2,000 $188.88 $377,760 Yes
2019-02-07 SUGAR RONALD D Director Sell 2,000 $190.00 $380,000 Yes
2018-12-06 Jacks Tyler Director Sell 20,000 $195.41 $3,908,232 Yes
2018-11-29 Patton Cynthia M SVP & CCO Sell 1,777 $202.88 $360,520 Yes
2018-07-16 Harper Sean E EVP, Research & Development Sell 1,525 $195.71 $298,458 No
2018-06-12 Harper Sean E EVP, Research & Development Sell 1,525 $184.27 $281,012 No
2018-05-14 Harper Sean E EVP, Research & Development Sell 1,525 $174.10 $265,502 No
2018-04-12 Harper Sean E EVP, Research & Development Sell 1,525 $172.68 $263,337 No
2018-03-16 Harper Sean E EVP, Research & Development Sell 1,525 $189.75 $289,369 No
2018-02-14 Harper Sean E EVP, Research & Development Sell 1,525 $174.18 $265,624 No
2018-01-16 Harper Sean E EVP, Research & Development Sell 1,525 $185.62 $283,070 No
2017-12-12 Harper Sean E EVP, Research & Development Sell 1,525 $176.83 $269,666 No
2017-11-13 Harper Sean E EVP, Research & Development Sell 1,525 $171.58 $261,660 No
2017-11-08 de Carbonnel Francois Director Sell 4,000 $173.61 $694,422 No
2017-10-09 Harper Sean E EVP, Research & Development Sell 1,525 $185.95 $283,574 No
2017-05-31 BALTIMORE DAVID Director Sell 3,700 $153.93 $569,541 No
2017-05-24 Patton Cynthia M SVP & CCO Sell 2,922 $154.40 $451,164 No
2016-08-02 Such Annette Louise VP, Finance and CAO Sell 3,000 $174.59 $523,758 No
2016-05-04 Balachandran Madhavan EVP, Operations Sell 30,000 $154.12 $4,623,624 Yes
2016-04-29 Harper Sean E EVP, Research & Development Sell 21,875 $157.99 $3,456,134 No
2016-04-29 BALTIMORE DAVID Director Sell 3,312 $157.21 $520,684 No
2016-03-02 Bradway Robert A Chairman, CEO and President Sell 20,000 $146.48 $2,929,566 Yes
2015-08-31 de Carbonnel Francois Director Sell 5,000 $153.84 $769,192 No
2015-08-19 Hassan Fred Director Buy 3,010 $166.63 $501,562 No
2015-07-31 PELHAM JUDITH C Director Sell 5,035 $180.40 $908,314 No
2015-06-02 Patton Cynthia M SVP & CCO Sell 4,530 $157.06 $711,482 No

Insider Smart

MGM Resorts International (MGM) - If we were to pick one of the easy trade from the crash, it has to be MGM, checkout the impressive insider buying after crash. Do you really need more confidence to pull the trigger? That's the mental edge you need to work against fear.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.